| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMO | Common Stock | Options Exercise | $2.93M | +22.6K | +56.07% | $129.77 | 62.8K | Nov 2, 2021 | Direct | |
| transaction | TMO | Common Stock | Sale | -$190K | -300 | -0.48% | $633.26 | 62.5K | Nov 2, 2021 | Direct | F1, F2 |
| transaction | TMO | Common Stock | Sale | -$254K | -400 | -0.64% | $634.42 | 62.1K | Nov 2, 2021 | Direct | F1, F3 |
| transaction | TMO | Common Stock | Sale | -$2.36M | -3.72K | -5.99% | $635.73 | 58.4K | Nov 2, 2021 | Direct | F1, F4 |
| transaction | TMO | Common Stock | Sale | -$2.6M | -4.09K | -7% | $636.73 | 54.3K | Nov 2, 2021 | Direct | F1, F5 |
| transaction | TMO | Common Stock | Sale | -$2.33M | -3.65K | -6.72% | $637.87 | 50.6K | Nov 2, 2021 | Direct | F1, F6 |
| transaction | TMO | Common Stock | Sale | -$3.04M | -4.76K | -9.4% | $638.97 | 45.9K | Nov 2, 2021 | Direct | F1, F7 |
| transaction | TMO | Common Stock | Sale | -$2.02M | -3.16K | -6.89% | $639.98 | 42.7K | Nov 2, 2021 | Direct | F1, F8 |
| transaction | TMO | Common Stock | Sale | -$1.08M | -1.68K | -3.94% | $640.92 | 41K | Nov 2, 2021 | Direct | F1, F9 |
| transaction | TMO | Common Stock | Sale | -$449K | -700 | -1.71% | $642.03 | 40.3K | Nov 2, 2021 | Direct | F1, F10 |
| transaction | TMO | Common Stock | Sale | -$64.3K | -100 | -0.25% | $642.88 | 40.2K | Nov 2, 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMO | Stock Option (Right to Buy) | Options Exercise | $0 | -22.6K | -100% | $0.00* | 0 | Nov 2, 2021 | Common Stock | 22.6K | $129.77 | Direct | F11 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.96 to $633.41, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9) and (10) to this Form 4. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.05 to $634.86, inclusive. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.315 to $636.11, inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.33 to $637.32, inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $637.41 to $638.39, inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $638.45 to $639.435, inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $639.46 to $640.44, inclusive. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $640.595 to $641.59, inclusive. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $641.60 to $642.33, inclusive. |
| F11 | The option vested in four equal installments on February 24, 2017, 2018, 2019, and 2020. |